General Hospital Dr. J. Bencevic Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2009
NCT01832311
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Department of Ophthalmology, General Hospital Dr. J. Bencevic

Active Ingredients

Drugs in Phase 4 Trials (1)

ketorolac (acuvail) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataract (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1